Szot Matthew K bought CVKD
January 18, 2024 · Form 4 insider transaction
Szot Matthew K bought 250,000 shares of Cadrenal Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
250,000
Price
$0.00
Total value
N/A
InsiderSzot Matthew K
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateJanuary 18, 2024
Filing dateJanuary 19, 2024
Shares owned after250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.